Investigation proves Pfizer vaccine offers less than 1%

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
578
Investigation proves Pfizer vaccine offers less than 1% protection against COVID-19

An investigation by the Canadian COVID Care Alliance (CCCA) has found that Pfizer’s Wuhan coronavirus (COVID-19) vaccine only has an efficacy rate of 0.84 percent. They added that Pfizer’s vaccine has done “more harm than good.”

The CCCA recently published a video and an accompanying 50-page PDF presentation that provides a thorough explanation of their investigation of the recent data released by Pfizer regarding the development and testing of the Big Pharma company’s COVID-19 vaccine.

The video and presentation explain that the CCCA is merely quantifying and contextualizing Pfizer’s claim that taking its COVID-19 vaccine is an act of risk reduction. When the Big Pharma company first unveiled its vaccine to the public, it claimed that it showed 95 percent efficacy seven days after the second dose.

But the CCCA said that the 95 percent efficacy is the reduction of “relative risk,” and not “absolute risk,” which the organization said is the more accurate scientific measurement to judge efficacy.

According to the absolute risk reduction value, Pfizer’s COVID-19 vaccine only has an efficacy rate of 0.84 percent.

In Pfizer’s trials for its COVID-19 vaccine, only eight out of 18,198 vaccinated participants were reported to have developed COVID-19. In the unvaccinated placebo group, 162 out of 18,325 developed COVID-19.

For the untrained eye, this data shows that getting Pfizer’s COVID-19 vaccine makes a person less likely to contract the virus. But the trial data shows that, even without the vaccine, the risk of contracting coronavirus was “extremely low,” at 0.88 percent for the unvaccinated and 0.04 percent for the vaccinated.

This is where Pfizer got its 95 percent number from. The company took the relative difference between the vaccinated and unvaccinated groups.

But when taking all of the trial data into consideration, the actual net benefit, or absolute risk, of taking Pfizer’s COVID-19 vaccine is just 0.84 percent.

“How many people would have chosen to take the COVID-19 vaccines had they understood that they offered less than one percent overall benefit?” asked the CCCA. “It’s clear that Pfizer – and the agencies overseeing their trials – failed to follow established, high quality safety and efficacy protocols right from the beginning.”

Pfizer vaccine increases risk of illness
Pfizer’s trial data also proves that getting vaccinated increases a person’s risk of illness.

According to the organization, Pfizer’s six-month trial data showed a “level one evidence of harm.” It found that around 91.3 percent of people in the vaccinated group experienced adverse reactions to the experimental vaccine. “There’s no benefit to a reduction in cases if it comes at a cost of increased illness and death,” said the CCCA.

There was a 300 percent increase in the number of adverse events determined to have been caused by the dangerous vaccine in the vaccinated group. Severe adverse events, or side effects that can strongly interfere with a person’s ability to function normally, increased by 75 percent in the vaccinated group.

There was also a 10 percent increase in serious adverse events among the vaccinated. A serious adverse event involves hospitalization or a visit to a hospital’s emergency room. (Related: Pfizer buys pharmaceutical company that makes heart medication to solve the problem caused by mRNA vaccines.)

Furthermore, more people in the vaccinated group died than in the placebo group – 20 to 14.

“Any government that approved this medical intervention for its citizens should have ensured that the trial had used the appropriate clinical endpoints and high quality safety science,” said the CCCA. “Any government official who possesses this evidence and continues to allow its citizens to be inoculated with a toxic agent is, at the very least, negligent.”

Watch the CCCA’s entire presentation proving that Pfizer’s COVID-19 vaccines do more harm than good.

video: https://newstarget.com/2022-01-17-pfizer-vacc...covid.html

This video is from the KristallKlar channel on Brighteon.com.

Learn more about how dangerous Pfizer’s COVID-19 vaccines are by reading the latest articles at Vaccines.news.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Egan-Jones Backs DGB's Push for Ethan Allen Shakeup

Updated Category News Views 1

Proxy Fight Brews Over Ethan Allen's Future Here we are, embroiled in another classic showdown in the corporate boardroom, and this time it's over at Ethan Allen—home of those plush couches and dining tables. Egan-Jones proxy services just threw its weight behind all five of DGB Investment's nominees for Ethan Allen’s board. This kind of tug-of-war isn't new, but each...

Continue Reading
Mendocino Farms Faces Allegations Over Employee Practices

Updated Category News Views 4

Mendocino Farms Lands in Legal Hot Water Jobs pay the bills and keep the gears turning. But when a company like Mendocino Farms allegedly chucks out the rulebook, things get messy fast. We're talking about a hefty lawsuit aimed at this chain, accusing them of playing fast and loose with California's labor laws. If you've been around the block like me, you know that...

Continue Reading
Tampa General's Tech Triumphs in Healthcare Innovation

Updated Category News Views 10

Spotlight on Tampa General's Technological Edge Wow, just when you think you've seen it all in the healthcare sector, here comes Tampa General Hospital (TGH) shaking things up again. Making waves by earning a spot among the "World's Best Smart Hospitals for 2027" by Newsweek and Statista, TGH's proving that tech-savvy isn't just for Silicon Valley startups. Folks, being...

Continue Reading
TBL Carves New Path with New York License Win

Updated Category News Views 5

Punching Through to New Opportunities Folks, here's one for the record books: the Team Boxing League (TBL) just nabbed the promoter license from the New York State Athletic Commission, or NYSAC if you're into the alphabet soup. This isn't just paperwork getting shuffled around an office; it's a massive leap forward for team boxing, a sport that steps into the heart of New...

Continue Reading
Nasdaq Backs Marketplace to Boost Financial Literacy

Updated Category News Views 7

Marketplace Gets a Leg Up with Nasdaq Grant Stumbled across this gem out of Saint Paul, and I gotta admit, it's nice to see folks focusing on the basics for a change. American Public Media's Marketplace lands a grant from the Nasdaq Foundation. And not just any grant—this one’s tagged as the Economic Opportunity Grant, all set to roll out expanded financial literacy...

Continue Reading
Escalade to Unveil Q3 2026 Results and Host Call

Updated Category News Views 6

Details on Escalade's Upcoming Financial Revelation Evansville's own Escalade, Inc. (NASDAQ: ESCA) is set to drop its third quarter 2026 financial results on October 29, well before your breakfast is done. For anyone following this stock, it's like waiting for the last few seconds of a tied basketball game. This isn’t just about numbers – it’s about a whole host of...

Continue Reading
Reel Drops: Eightpoint's New Social Drama App Explored

Updated Category News Views 1

Mobile Drama: A Quick Escape with Reel Drops In this fast-moving world, where time feels as elusive as a daydream, Eightpoint is shaking up mobile entertainment with its brand-new app, Reel Drops. Based out of George Town, Cayman Islands, this app aims to give viewers a shot at swift, captivating storytelling without the marathon commitment of a binge-watch session. A New...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 2

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
KarbunWise Unveils Game-Changing LCA Tool at Greenbuild

Updated Category News Views 0

Disruptive Tech Meets Green Standards New York got hit with a sustainability tidal wave at this year’s Greenbuild Expo. KarbunWise is making some serious noise with their new platform that's all about minimizing the carbon footprint in construction projects—there’s nothing passive about it. If you haven't heard, the Expo theme is “Invest for Impact,” which is...

Continue Reading
Cboe Clear's US Move: A New Chapter with SEC Nod

Updated Category News Views 2

Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Military Products Forms Significant Defense Partnership

Updated Category News Views 91

Strategic Partnership Announcement Global Military Products, a prominent provider of defense solutions, is pleased to announce a remarkable new partnership with Tripwire South LLC and Astor Defense. This collaboration secures a long-term supply agreement for TNT (Trinitrotoluene), a crucial energetic material utilized in a variety of ordnance solutions. Details of the...

Continue Reading
Celebrating a Successful Year: Prosper and Alliant Union

Updated Category News Views 196

Prosper and Alliant Credit Union Celebrate Their Partnership Prosper Marketplace, known as the first peer-to-peer lending platform in the United States, and Alliant Credit Union, the largest credit union in Illinois, are celebrating the first anniversary of their strategic partnership. Together, they have successfully provided over $325 million in loans to more than...

Continue Reading
Potential of Polygenic Risk Scores to Reduce Preventable Deaths

Updated Category News Views 247

The Role of Polygenic Risk Scores in Public Health Recent research demonstrates a groundbreaking approach to healthcare using polygenic risk score (PRS) screening, which has the potential to prevent a significant portion of premature deaths caused by chronic diseases. The findings indicate that nearly one in five deaths in the US is preventable, highlighting the urgency...

Continue Reading
FACT II Acquisition Corp. Launches $175 Million IPO for Growth

Updated Category News Views 103

FACT II Acquisition Corp. Initial Public Offering Details FACT II Acquisition Corp. has recently announced the successful pricing of its initial public offering (IPO), which aims to raise $175 million. This exciting step reflects the company's commitment to growth and investment in promising business ventures. The IPO consists of 17,500,000 units priced at $10.00 each,...

Continue Reading
Market Insights: Fed Decision-Impact Amid Earnings Season

Updated Category News Views 52

Understanding Market Movements As we delve into the latest developments in U.S. and global markets, it is crucial to understand the impact of upcoming Federal Reserve decisions and ongoing earnings reports from prominent banks. Federal Reserve's Potential Rate Pause Recent fluctuations in futures pricing have raised concerns as we anticipate the Federal Reserve's next...

Continue Reading